Skip To Main Content
C. Byrne on Muck Rack

C. Byrne

United Kingdom
As seen in: Color Research & Application, Wiley Online Library, Goal, Veterinary Record, Science Magazine, BioRxiv, The New Statesman, The St. Augustine Record, Tribune-Star, Times Colonist and
Releasing music under names inc. Grotesqo bit.ly/music-is-vast-a-tribute-to-the-music-and-legacy-of-vangelis

Get in touch with C.

Contact C., search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

C. Byrne’s Biography

Read Full Bio →

freelance writer & teacher (amongst other things)

C. Byrne’s Journalist Portfolio

The beginnings of a new prejudice

The beginnings of a new prejudice

I am 29 years old, born and bred in Aldershot, Hampshire. I have lived in England all my life with no crimina…

View article →

Articles

MASLD In PBC: A Shift From Liver-Centred to Cardiometabolic Risk Assessment?

|
By C. Byrne, Francesca Colapietro, Mauro Viganò
| Wiley Online Library Verified
The coexistence of primary biliary cholangitis (PBC) and metabolic dysfunction-associated steatotic liver disease (MASLD) is becoming increasingly common in clinical practice. As the global prevalence of obesity, type 2 diabetes mellitus and metabolic syndrome continues to rise, hepatologists are confronted with patients who harbour both autoimmune cholestatic liver disease and metabolic liver injury.
Open in Who Shared Issue with article?

MASH-Related Liver Cancer Estimates Need Aetiology-Specific Validation in the Asia-Pacific Region

|
By C. Byrne, Christopher Byrne, Haoyang Hu
| Wiley Online Library Verified
No abstract is available for this article. Data Availability Statement Data sharing not applicable to this article as no datasets were generated or analysed during the current study. References 1, , , et al., “Burden and Regional Disparities of MASH-Related Liver Cancer in the Asia-Pacific Region From 1990 to 2023,” Liver International 46 (2026): e70752. 2, , and , “Metabolic Dysfunction-Associated Steatotic Liver Disease,” New England Journal of Medicine 393 (2025): 683–698.
Open in Who Shared Issue with article?

The metabolomic signatures mediate associations between physical frailty and metabolic dysfunction–associated steatotic liver disease

|
By C. Byrne, G. Targher, Xuhong Yang, David Anthony Verified, Dazhi Wang, Rongtao Jiang, Matthew Rosenblatt, Shile Qi, Vince Calhoun, Qian Wang, Peng Wang, Jing Wu, Dustin Scheinost, Jing Sui
| Science Magazine Verified
Abstract INTRODUCTION RESULTS DISCUSSION MATERIALS AND METHODS Acknowledgments Supplementary Materials REFERENCES Information & Authors Metrics & Citations View Options References Figures Tables Media Share Abstract Prevention remains a key strategy to address the growing burden of metabolic dysfunction–associated steatotic liver disease (MASLD), highlighting the importance of exploring modifiable risk factors. Accumulating evidence suggests a close link between physical frailty and MASLD.
Open in Who Shared Issue with article?
See all 44 licensed articles (45 Total)